Carrie Smith Cox
Disclosed holdings of Carrie Smith Cox as of 2026-05-13: 38K shares of Texas Instruments (TXN), worth about $11.3M at the last close and 2 other companies. In…
What Carrie Smith Cox reported holding
As of the latest filing on , Carrie Smith Cox reported holding 37,626 shares of Texas Instruments (TXN), worth about $11.3M at the last close of $301 (Oct 30, 2026). Holdings are also on file at Solventum (SOLV), Organon & Co. (OGN); together they are worth about $12.8M. In the last 12 months, Carrie Smith Cox sold $2.71M in 2 sales.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Texas Instruments TXN | 37,626 | 38K direct | $301 | $11.3M | May 13, 2026 |
| Solventum SOLV | 16,400 | 16K direct | $81 | $1.33M | Apr 30, 2026 |
| Organon & Co. OGN | 12,469 | 12K direct | $14 | $173K | May 14, 2025 |
Is this Carrie Smith Cox’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Insider buying and selling since 2007
Carrie Smith Cox bought shares on the open market in 8 different years since 2007 across 6 companies. Sales in 8 of the 20 years since 2007.
Carrie Smith Cox reported 10 open-market purchases and 38 sales since 2007; purchases in 8 different years, most recently 2025.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | 2×2 trades |
| 2025 | 1×1 trade | — |
| 2023 | — | 1×1 trade |
| 2022 | 1×1 trade | — |
| 2021 | 1×1 trade | — |
| 2020 | — | 2×2 trades |
| 2019 | 1×1 trade | 1×1 trade |
| 2018 | 3×3 trades | — |
| 2017 | — | 1×1 trade |
| 2015 | — | 2×2 trades |
| 2013 | 1×1 trade | 1×1 trade |
| 2008 | 1×1 trade | — |
| 2007 | 1×1 trade | 28×28 trades |
Insider at 6 companies
- Texas Instruments TXN2007–2026 · 2 purchases, 10 sales
- Organon & Co. OGN2025 · 1 purchase, 0 sales
- Cartesian Therapeutics RNAC2021–2022 · 2 purchases, 0 sales
- Electrocore ECOR2018–2019 · 4 purchases, 0 sales
- Cardinal Health CAH2013 · 1 purchase, 0 sales
- Merck MRK2007 · 0 purchases, 28 sales
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
The companies behind these filings
- Merck MRK
Carrie Smith Cox reported 0 open-market purchases and 28 sales here, 2007.
- Market value
- $369B
- Last close
- $149.52
- 12 months
- +73.3%
- Against the S&P 500
- +62.1 pts
- Net margin
- 28.1%
- Revenue (last year)
- $65B
- Texas Instruments TXN
Carrie Smith Cox reported 2 open-market purchases and 10 sales here, 2007 to 2026.
- Market value
- $275B
- Last close
- $300.84
- 12 months
- +87.4%
- Against the S&P 500
- +76.3 pts
- Net margin
- 28.3%
- Revenue (last year)
- $17.7B
- Electrocore ECOR
Carrie Smith Cox reported 4 open-market purchases and 0 sales here, 2018 to 2019.
- Market value
- $67.8M
- Last close
- $7.52
- 12 months
- +54.1%
- Against the S&P 500
- +42.9 pts
- Net margin
- -43.6%
- Revenue (last year)
- $32M
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Free account: get the written context of this page. Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Carrie Smith Cox's trades
Has Carrie Smith Cox bought shares on the open market?
Carrie Smith Cox bought shares on the open market in 8 different years since 2007 across 6 companies. Sales in 8 of the 20 years since 2007.
When did Carrie Smith Cox last buy or sell shares?
In SEC filings since 2007: the latest open-market purchase is from 2025; the latest open-market sale is from 2026.
Which companies has Carrie Smith Cox traded as an insider?
6 companies: Texas Instruments (TXN, 2007–2026), Organon & Co. (OGN, 2025), Cartesian Therapeutics (RNAC, 2021–2022), Electrocore (ECOR, 2018–2019), Cardinal Health (CAH, 2013) and others.